News

Start-up secures Series A funding round for wearable urinary incontinence device

By Published On: February 15, 2024
Start-up secures Series A funding round for wearable urinary incontinence device

The US health tech company Elidah has announced the completion of its Series A funding round to raise awareness of urinary incontinence.

Elidah, the start-up behind two wearable urinary incontinence treatments for women, has secured an undisclosed amount in investment led by Blu Venture Investors.

Urine incontinence is a common symptom that affects 50 per cent of adult women. Prevalence of this increases with age, as up to 75 per cent of women over 65 report urine leakage.

Elitone and Elitone URGE, developed by Elidah, are the only FDA-cleared external solutions designed to help women tone their pelvic floor and calm their overactive bladder.

The devices aim to deliver neuromuscular stimulation to the pelvic floor to treat loss of urinary control. Small electrical currents travel through the muscles in the perineal area between four areas of conductive gel. Treatment sessions last 20 minutes and can be done while dressed and active.

Gloria Kolb, co-founder and CEO of Elidah, said: “The Series A funding round presents an opportunity for us to expand our reach, streamline insurance processes and explore new markets that can benefit from the treatment.”

The start-up plans to use the funding to raise awareness of incontinence and improve distribution channels for its two wearable products.

Bikram Bakshi, partner at Blu Venture Investors, said: “Blu Ventures is pleased to lead this round.

“Elidah embodies the characteristics that make for a great investment: very large market, strong team, novel product with key regulatory hurdles behind them.

“The added bonus that won us over, was that the founding team accomplished so much with so little previous funding.  We are delighted to be part of a team that is positively changing a lot of women’s lives.”

A recent report from the World Economic Forum has found that investing in women’s health can not only addresses health disparities and improve women’s wellbeing but also lead to a 1.7 per cent per capita increase in Gross Domestic Product (GDP), fostering greater participation in the workforce.

The report has shown that every US$1 invested in women’s health generates US$3 in global economic growth.

Samsung launches women's health ultrasound digital platform
'No more cute mentorship programmes': femtech community reacts to Women's Health Strategy